← FDA Drug Approvals (Drugs@FDA)

ATRACURIUM BESYLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2017-06-22

Drug application

FDA Application #

ANDA206096

Application type

Abbreviated New Drug Application (Generic)

Brand name

ATRACURIUM BESYLATE

Generic name

Atracurium Besylate

Active ingredients

ATRACURIUM BESYLATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

PHARMOBEDIENT

First approval

2017-06-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown